Iris registration is a good compensator of cyclotorsion

Article

Compensation of cyclotorsion using iris registration can be helpful in decreasing misalignment of the axis of correction and in improving the overall outcome of LASIK, according to a study to be published in the April 2008 issue of the Journal of Cataract & Refractive Surgery.

Compensation of cyclotorsion using iris registration can be helpful in decreasing misalignment of the axis of correction and in improving the overall outcome of LASIK, according to a study to be published in the April 2008 issue of the Journal of Cataract & Refractive Surgery.

Hyojin Kim and Choun-Ki Joo performed the study, to evaluate the degree and direction of ocular cyclotorsion according to body position and flap creation before LASIK, at Kangnam St Mary's Hospital, Seoul, Republic of Korea.

The rotational position and degree were measured in 140 eyes of 70 patients with myopia or myopic astigmatism. Preoperatively, an iris image of each eye was examined using the Visx WaveScan Wavefront System (AMO) iris-registration feature with the patient seated. A Visx Star S4 laser (AMO) was used to measure cyclotorsion on the images before flap creation with the patient supine. The iris image was measured again after flap creation with the patient supine. The hinge of the LASIK flap was placed on the superior side and by rotating from the right to left side.

The mean cyclotorsional misalignment was 2.59 degrees±1.91 (SD) (right eye, 2.67±2.00 degrees; left eye, 2.51±1.98 degrees). Twenty eyes (13.0%) had cyclotorsion greater than 5 degrees. Seventy-six eyes (54.3%) had excyclotorsion. After flap creation, 107 eyes (76.4%) and 27 eyes (19.3%) rotated in the direction of identity and opposition, respectively. In eyes with cyclotorsion of identical direction, the mean increase was 1.27±0.99 degrees and 1.19±1.08 degrees in the excyclotorsion direction and incyclotorsion direction, respectively.

From these results, the authors concluded that compensation of cyclotorsion using iris registration can be helpful in decreasing misalignment of the axis of correction and in improving the overall outcome of LASIK.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.